PMID: 9421803Jan 9, 1998Paper

Oxidation of low-density lipoprotein and atherosclerosis in chronic renal failure

Medical Hypotheses
O Hasselwander, I S Young

Abstract

The major cause of death in patients with end-stage renal failure receiving renal replacement therapy is cardiovascular disease. Oxidation of low-density lipoprotein (LDL) is recognized as a key early stage in the development of atherosclerosis, leading to uptake of LDL by the macrophage scavenger receptor and hence to foam cell formation. However, several studies have suggested that the susceptibility of LDL to oxidation is not increased in chronic renal failure. We propose a number of mechanisms which may lead to increased lipoprotein oxidation in vivo, and hence contribute to increased atherosclerosis in renal failure.

References

Jun 1, 1979·Scandinavian Journal of Clinical and Laboratory Investigation·T HenriksenB Carlander
Jan 1, 1992·European Journal of Clinical Pharmacology·T J DenglerH J Dengler
May 1, 1992·Kidney International·S HörkköY A Kesäniemi
Nov 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·V W BowryR Stocker
Oct 1, 1992·Free Radical Biology & Medicine·H EsterbauerG Jürgens
Aug 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·S T KunitakeJ P Kane
Apr 30, 1992·Clinica Chimica Acta; International Journal of Clinical Chemistry·B C WilkeM J Richard
Dec 1, 1991·The Journal of Clinical Investigation·J L Witztum, D Steinberg
Jun 1, 1991·Diabetic Medicine : a Journal of the British Diabetic Association·T J Lyons
Jan 1, 1991·Free Radical Biology & Medicine·S P WolffJ V Hunt
Sep 1, 1991·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·R M ZwijsenI C Nusselder
Jan 1, 1991·Kidney International·G Appel
Dec 1, 1990·Baillière's Clinical Endocrinology and Metabolism·C D Short, P N Durrington
Dec 1, 1990·Biochemical Society Transactions·E R Skinner, H M Wilson
May 22, 1990·Biochimica Et Biophysica Acta·S ParthasarathyL G Fong
Mar 1, 1989·The Biochemical Journal·P G WinyardD R Blake
Mar 28, 1974·The New England Journal of Medicine·A LindnerB H Scribner
May 1, 1981·Kidney International·M K ChanJ F Moorhead
Jul 1, 1995·Kidney International·S E RoselaarD R Blake
Jul 1, 1995·Kidney International·W H SutherlandM C Robertson
Sep 25, 1995·Biochemical and Biophysical Research Communications·H E RoxboroughI S Young
Apr 1, 1995·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·T SchulzR Lorenz
Oct 1, 1994·Atherosclerosis·C M LoughreyE R Trimble
Apr 1, 1993·Atherosclerosis·A N KlimovN P Teryukova
Feb 1, 1993·Kidney International·J JovenJ D Brunzell
Apr 1, 1993·The American Journal of Medicine·J L Witztum
Jun 1, 1993·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·P O AttmanP Alaupovic
Aug 1, 1995·Medical Hypotheses·H E Roxborough, I S Young
Nov 1, 1995·Kidney International·J StimG Dunea

❮ Previous
Next ❯

Citations

Jan 16, 2009·Pediatrics International : Official Journal of the Japan Pediatric Society·Lorenzo IughettiFiorella Balli
Sep 11, 1998·Free Radical Research·O Hasselwander, I S Young
Dec 19, 2002·European Journal of Clinical Investigation·G SchippingerG Halwachs

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.